Aspiriant LLC’s Nuveen ESG Emerging Markets Equity ETF NUEM Stock Holding History

Aspiriant LLC’s Portfolio NUEM Stock Details NUEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$354K	Hold	9,622	–	–	0.01%	254
2025 Q4	$342K	Hold	9,622	–	–	0.01%	258
2025 Q3	$343K	Hold	9,622	–	–	0.01%	235
2025 Q2	$320K	Hold	9,622	–	–	0.01%	243
2025 Q1	$281K	Hold	9,622	–	–	0.01%	244
2024 Q4	$279K	Sell	9,622 -1,046	-10%	-$31.9K	0.01%	241
2024 Q3	$331K	Hold	10,668	–	–	0.01%	224
2024 Q2	$306K	Buy	+10,668	New	+$298K	0.01%	225

Other funds holding NUEM

TCIIS

TIAA-CREF Individual & Institutional Services New York $26B AUM

Wealthfront Advisers Palo Alto, California $45.6B AUM 18.83% 1-Year Est. Return

AWP

Abacus Wealth Partners Santa Monica, California $1.1B AUM 14.74% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

TFM

TFC Financial Management Boston, Massachusetts $812M AUM 17.34% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

CCM

Colorado Capital Management Boulder, Colorado $293M AUM 22.17% 1-Year Est. Return

CPO

Cerity Partners OCIO New York $1.67B AUM 13.22% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Aspiriant LLC's NUEM Position: Q1 2026 in Review

Aspiriant LLC held its Nuveen ESG Emerging Markets Equity ETF (NUEM) position steady in Q1 2026 at 9,622 shares worth $354K. The position accounts for 0.01% of the portfolio, ranked #254.

Aspiriant LLC first reported a position in NUEM in Q2 2024 and has held it in 8 quarters since. 120 funds tracked by Wall St. Rank hold NUEM as of Q1 2026.

Aspiriant LLC held 9,622 shares of Nuveen ESG Emerging Markets Equity ETF worth $354K as of Q1 2026.
Aspiriant LLC left its Nuveen ESG Emerging Markets Equity ETF share count unchanged in Q1 2026.
Nuveen ESG Emerging Markets Equity ETF made up 0.01% of Aspiriant LLC's portfolio in Q1 2026, its #254 holding.
Aspiriant LLC first reported a position in Nuveen ESG Emerging Markets Equity ETF in Q2 2024 and has held it in 8 quarters since.
120 funds tracked by Wall St. Rank held Nuveen ESG Emerging Markets Equity ETF as of Q1 2026.

Based on Aspiriant LLC's 13F filing for Q1 2026, filed 12 May 2026.